V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002197 | 230006700 | 1.61 | 65.9 | null | 2017-10-05 | 2017-10-06 | Bevacizumab+Carbo+Pacliaxel | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100121097 |
| 230002198 | 230006701 | 1.57 | 48 | null | 2019-02-15 | 2019-06-29 | null | 02 | null | CYCLOPHOSPHAMIDE | 101045619 |
| 230002199 | 230006702 | null | null | Curative (C) | 2020-06-12 | 2020-06-12 | Niraparib | 02 | null | NIRAPARIB | 100988405 |
| 230002200 | 230006703 | 1.55 | 85 | null | 2019-12-06 | 2019-12-20 | null | N | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101510202 |
| 230002203 | 230006705 | null | null | null | 2020-01-03 | 2020-02-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100680507 |
| 230002207 | 230006707 | 1.64 | 73.1 | null | 2020-03-19 | 2020-10-13 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100544319 |
| 230002208 | 230006708 | 1.57 | 72.3 | null | null | 2021-11-12 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100417143 |
| 230002210 | 230006709 | null | null | 03 | 2019-05-24 | 2019-06-03 | null | 02 | N | METHOTREXATE | 100975773 |
| 230002211 | 230006710 | 1.74 | 59.3 | null | null | 2018-05-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101395853 |
| 230002213 | 230006712 | 1.57 | 89 | null | null | 2020-12-20 | Niraparib | 02 | null | NIRAPARIB | 100396177 |
| 230002215 | 230006713 | 1.59 | 68.7 | Adjuvant (A) | 2021-01-12 | 2021-02-02 | Trial Unspecified | 02 | N | NIVOLUMAB | 100115300 |
| 230002217 | 230006714 | 1.47 | 97.6 | Palliative (P) | 2019-03-05 | 2019-03-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101241691 |
| 230002218 | 230006715 | 1.67 | 91.55 | null | null | 2019-05-28 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100917486 |
| 230002223 | 230006718 | null | null | null | 2021-07-29 | 2021-08-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101466493 |
| 230002225 | 230006719 | 1.44 | 58.6 | null | null | 2018-04-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101600305 |
| 230002226 | 230006720 | 1.51 | 65 | null | 2021-02-14 | 2021-08-21 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100126004 |
| 230002231 | 230006722 | 1.49 | 68.5 | null | 2020-04-14 | 2020-04-19 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100733877 |
| 230002233 | 230006723 | 1.52 | 83 | null | 2018-02-01 | 2018-02-17 | Carboplatin AUC 6 - 10 | 02 | null | CISPLATIN | 101079093 |
| 230002234 | 230006724 | 1.54 | 61.2 | Adjuvant (A) | null | 2020-03-14 | ICON8B TRIAL | 02 | N | TRIAL UNSPECIFIED | 101273499 |
| 230002237 | 230006726 | 1.71 | 55.2 | Palliative (P) | null | 2019-07-12 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100107581 |
| 230002239 | 230006727 | 1.59 | 77.2 | null | null | 2018-03-02 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101256331 |
| 230002240 | 230006728 | 1.62 | 70 | null | 2020-11-14 | 2020-12-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101504664 |
| 230002244 | 230006730 | 1.59 | 86.4 | null | 2020-07-03 | 2020-07-06 | Niraparib | 02 | null | NIRAPARIB | 101352979 |
| 230002246 | 230006731 | null | null | null | null | 2019-10-20 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100259364 |
| 230002247 | 230006732 | 1.55 | 89.5 | null | 2020-07-29 | 2020-09-22 | null | 02 | null | CVP R | 100327150 |
| 230002251 | 230006735 | 1.67 | 86.5 | null | null | 2020-02-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100636113 |
| 230002252 | 230006736 | 1.56 | 59 | null | 2019-12-06 | 2019-12-28 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101589084 |
| 230002257 | 230006739 | 1.57 | 85 | null | 2020-01-05 | 2021-05-02 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100731899 |
| 230002261 | 230006743 | null | null | null | 2016-10-23 | 2016-11-01 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101114523 |
| 230002262 | 230006744 | 1.66 | 72 | null | null | 2021-06-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101081235 |
| 230002263 | 230006745 | 1.62 | 69.8 | Palliative (P) | null | 2020-10-13 | null | null | N | ETOPOSIDE | 101358969 |
| 230002264 | 230006746 | 1.56 | 67.8 | Neo-adjuvant (N) | null | 2019-09-09 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101792400 |
| 230002266 | 230006748 | 1.46 | 66.55 | Palliative (P) | null | 2020-07-27 | NIVOLUMAB | 02 | N | CISPLATIN + ETOPOSIDE | 101259615 |
| 230002268 | 230006749 | 1.6 | 56.1 | Palliative (P) | 2019-09-15 | 2020-01-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101222694 |
| 230002271 | 230006751 | 1.62 | 76.7 | null | null | 2018-06-29 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101413735 |
| 230002272 | 230006752 | 1.55 | 38.3 | null | 2020-10-19 | 2020-10-27 | Rucaparib | 02 | null | RUCAPARIB | 101277414 |
| 230002274 | 230006753 | 1.68 | 88.8 | null | null | 2019-09-01 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100560810 |
| 230002276 | 230006754 | null | null | null | 2016-05-23 | 2018-09-27 | null | null | null | TRIAL UNSPECIFIED | 101517083 |
| 230002279 | 230006756 | 1.59 | null | 03 | 2016-11-14 | 2016-11-14 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101544684 |
| 230002281 | 230006757 | 1.6 | 62 | null | 2020-06-23 | 2020-06-28 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100728949 |
| 230002282 | 230006758 | 1.6 | 84 | null | null | 2022-03-24 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100297974 |
| 230002283 | 230006759 | null | null | Palliative (P) | 2018-08-24 | 2018-09-05 | PACLITAXEL | 02 | N | PACLITAXEL | 100756266 |
| 230002284 | 230006760 | null | null | null | 2021-06-26 | 2021-06-27 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100866680 |
| 230002286 | 230006762 | 1.54 | 53.6 | null | 2019-01-09 | 2019-05-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100750655 |
| 230002288 | 230006763 | 1.61 | 93 | null | 2020-08-06 | 2020-08-06 | null | 02 | null | TRIAL UNSPECIFIED | 101757498 |
| 230002292 | 230006767 | 1.51 | 58.4 | Adjuvant (A) | 2019-11-27 | 2019-11-27 | Bevacizumab | 02 | N | BEVACIZUMAB | 100400954 |
| 230002293 | 230006768 | 1.61 | 82 | Palliative (P) | 2019-07-10 | 2019-07-15 | PACLITAXEL | 02 | N | PACLITAXEL | 100965355 |
| 230002294 | 230006769 | 1.62 | 45 | null | 2019-08-31 | 2019-09-03 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100533775 |
| 230002296 | 230006770 | 1.57 | 83.7 | Curative (C) | null | 2017-01-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100130750 |
| 230002299 | 230006772 | null | 50.6 | Adjuvant (A) | null | 2020-10-29 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101089932 |